唾液可的松在肾上腺意外瘤过夜地塞米松抑制试验中的应用价值
该回顾性分析纳入173例肾上腺意外瘤患者,评估过夜地塞米松抑制试验后唾液可的松与血清皮质醇的相关性。结果显示地塞米松后唾液可的松与血清皮质醇强相关(r=0.95),预测血清皮质醇≤50 nmol/L的敏感性和特异性与联合指标相当,提示唾液可的松可作为无需静脉穿刺和到院的替代采样方法。
要点
- 肾上腺意外瘤患者过夜地塞米松抑制试验后,唾液可的松与血清皮质醇强相关(r=0.95)。
- 地塞米松后唾液可的松单独预测血清皮质醇≤50 nmol/L的敏感性85.3%、特异性91.7%、kappa 0.77。
- 唾液可的松可作为无需静脉穿刺和到院的替代采样方法。
核心结论
- 在肾上腺意外瘤患者中,地塞米松后唾液可的松与过夜地塞米松抑制试验中的血清皮质醇强相关,可作为无需静脉穿刺或到院的替代采样方法。
研究设计与样本
- 回顾性分析173例接受过夜地塞米松抑制试验及唾液皮质醇/可的松昼夜研究的肾上腺意外瘤患者。
- 在地塞米松前09:00、深夜及地塞米松后次日09:00采集血清和唾液皮质醇及唾液可的松,并测定地塞米松后样本中的地塞米松水平,采用液相色谱-串联质谱法分析。
主要发现
- 1 mg地塞米松后唾液可的松与血清皮质醇强相关(r=0.95)。
- 逐步多因素回归显示,地塞米松后唾液可的松、基线血清皮质醇、唾液可的松抑制率(地塞米松前/后比值)和性别是唯一显著或接近显著的独立变量。
- 使用上述4个参数的预测指数(敏感性88.5%,特异性91.2%;kappa 0.80)与单用地塞米松后唾液可的松(敏感性85.3%,特异性91.7%;kappa 0.77)在预测过夜地塞米松抑制试验血清皮质醇≤50 nmol/L时表现相当。
- 未观察到与其他所测参数的相关性。
关键数值与推荐
- 预测过夜地塞米松抑制试验血清皮质醇≤50 nmol/L:4参数预测指数敏感性88.5%、特异性91.2%、kappa 0.80。
- 预测过夜地塞米松抑制试验血清皮质醇≤50 nmol/L:单用地塞米松后唾液可的松敏感性85.3%、特异性91.7%、kappa 0.77。
临床怎么用
- 在肾上腺意外瘤患者中,地塞米松后唾液可的松可作为过夜地塞米松抑制试验的替代采样方法,无需静脉穿刺或到院。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Guidelines recommend the assessment of cortisol secretion in patients with adrenal incidentalomas (AI) using the overnight dexamethasone suppression test (ONDST). This requires attendance at a health care facility and venepuncture. Alternatively, the ONDST can be done by measuring salivary cortisol and cortisone, which can be collected at home. OBJECTIVE: We aimed to assess the utility of these measurements in patients with AI. METHODS: A retrospective analysis of data from 173 patients with AI who underwent an ONDST and salivary cortisol/cortisone diurnal studies. Serum and salivary cortisol and salivary cortisone were collected at 09:00, late night, and at 09:00 the following morning after dexamethasone. Dexamethasone levels were measured in the postdexamethasone samples. Serum and salivary samples were analyzed with liquid chromatography-tandem mass spectrometry. RESULTS: We identified a strong correlation between salivary cortisone and serum cortisol after 1 mg of dexamethasone (r = 0.95). Stepwise multivariate regression showed that postdexamethasone salivary cortisone, baseline serum cortisol, salivary cortisone suppression (predexamethasone/postdexamethasone ratio), and sex were the only significant or near-significant independent variables. Performance of predictive indices using these 4 parameters (sensitivity = 88.5%, specificity = 91.2%; kappa 0.80) and postdexamethasone salivary cortisone alone (sensitivity = 85.3%, specificity = 91.7%; kappa 0.77) were comparable when used to predict an ONDST serum cortisol of ≤50 nmol/L. No correlation was observed with any of the other measured parameters. CONCLUSION: In AI patients, after dexamethasone, salivary cortisone correlates very strongly with serum cortisol in the ONDST and could therefore be used as an alternative sampling method which does not require venepuncture or attendance at hospital.
引用
- Issa BG, Hanna FWF, Fryer AA, et al. The Utility of Salivary Cortisone in the Overnight Dexamethasone Suppression Test in Adrenal Incidentalomas. J Clin Endocrinol Metab. 2023. PMID: 37155577. doi:10.1210/clinem/dgad242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。